Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
Clinical trial NCT04977986 · COMPLETED
Trial details
- NCT number
- NCT04977986
- Sponsor
- Zynerba Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2025-08-29
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.